{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:59:03Z","timestamp":1791057543974,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.urology.2010.11.002","type":"journal-article","created":{"date-parts":[[2011,2,6]],"date-time":"2011-02-06T09:09:59Z","timestamp":1296983399000},"page":"1009.e19-1009.e25","source":"Crossref","is-referenced-by-count":44,"title":["Angiotensin II Type 1 Receptor Expression and Microvessel Density in Human Bladder Cancer"],"prefix":"10.1016","volume":"77","author":[{"given":"Suguru","family":"Shirotake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2010.11.002_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2010.11.002_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non\u2013muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.11.002_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non\u2013muscle-invasive bladder cancer: from epidemiology to treatment strategy","volume":"56","author":"Bas","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.11.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis correlation in invasive breast carcinoma","volume":"324","author":"Weidner","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2010.11.002_bib5","first-page":"5281","article-title":"Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer","volume":"57","author":"Crew","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2010.11.002_bib6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/annonc\/mdg377","article-title":"Neovascularisation is a prognostic factor of early recurrence in T1\/G2 urothelial bladder tumours","volume":"14","author":"Santos","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urology.2010.11.002_bib7","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1158\/1078-0432.CCR-08-0677","article-title":"Angiogenic switch of angiopoietins-Tie2 system and its prognostic value in bladder cancer","volume":"14","author":"Szarvas","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2010.11.002_bib8","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1158\/1078-0432.CCR-05-2213","article-title":"Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer","volume":"12","author":"Kosugi","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2010.11.002_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-0774.2007.00025.x","article-title":"Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer","volume":"20","author":"Kosugi","year":"2007","journal-title":"Hum Cell"},{"key":"10.1016\/j.urology.2010.11.002_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pros.20486","article-title":"Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer","volume":"67","author":"Kosaka","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2010.11.002_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2010.11.002_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI16645","article-title":"Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth","volume":"112","author":"Egami","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.urology.2010.11.002_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0006-291X(02)00496-5","article-title":"Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis","volume":"294","author":"Fujita","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.urology.2010.11.002_bib14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.bjc.6601646","article-title":"Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma","volume":"90","author":"Juillerat-Jeanneret","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2010.11.002_bib15","series-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","year":"2004"},{"key":"10.1016\/j.urology.2010.11.002_bib16","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.juro.2010.01.018","article-title":"Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers","volume":"183","author":"Shahrokh","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.11.002_bib17","first-page":"401","article-title":"Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma","volume":"143","author":"Weidner","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urology.2010.11.002_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-5793(01)02377-8","article-title":"Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist","volume":"495","author":"Fujimoto","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.urology.2010.11.002_bib19","first-page":"4176","article-title":"Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis","volume":"62","author":"Miyajima","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2010.11.002_bib20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ajog.2003.12.013","article-title":"Activation of invasiveness of cervical carcinoma cells by angiotensin II","volume":"190","author":"Kikkawa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.urology.2010.11.002_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pros.21049","article-title":"Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer","volume":"70","author":"Kosaka","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2010.11.002_bib22","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1158\/1535-7163.MCT-10-0535","article-title":"Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer","volume":"9","author":"Tanaka","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.urology.2010.11.002_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000019811","article-title":"Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer","volume":"35","author":"Crew","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.11.002_bib24","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/jnci\/87.21.1603","article-title":"Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis","volume":"87","author":"Bochner","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2010.11.002_bib25","first-page":"2583","article-title":"Microvessel density at presentation predicts subsequent muscle invasion in superficial bladder cancer","volume":"9","author":"Goddard","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2010.11.002_bib26","series-title":"Guidelines on TaT1 (non-muscle invasive) bladder cancer","author":"Babjuk","year":"2008"},{"key":"10.1016\/j.urology.2010.11.002_bib27","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-5347(01)61606-9","article-title":"Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up","volume":"161","author":"Solsona","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.11.002_bib28","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0022-5347(01)66226-8","article-title":"The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow-up","volume":"155","author":"Tolley","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.11.002_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other disease","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.urology.2010.11.002_bib30","doi-asserted-by":"crossref","first-page":"19485","DOI":"10.1073\/pnas.0909228106","article-title":"Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebra fish tumor model","volume":"106","author":"Lee","year":"2009","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510019552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510019552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T22:07:34Z","timestamp":1712182054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429510019552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0090429510019552"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2010.11.002","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}